SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXCH.L Regulatory News (XCH)

  • There is currently no data for XCH

Form 8.5 (EPT/RI) - Amendment

14 Oct 2015 17:45

RNS Number : 3098C
GoldmanSachs International
14 October 2015
 

Amendment - due to the amendment of Derivative transactions, the disclosure made on 08 Oct for dealings on 07 Oct has been updated. Section 2(b) has been updated.

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

XCHANGING PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

APOLLO GLOBAL MANAGEMENT LLC

(d) Date dealing undertaken:

07 October 2015

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

5p ordinary

Purchases

28,153

2.5882 USD

2.5842 USD

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

5p ordinary

CFD

Reducing a long position

8,423

2.5842 USD

5p ordinary

CFD

Reducing a long position

17,347

2.5842 USD

5p ordinary

CFD

Reducing a long position

1,755

2.5842 USD

5p ordinary

CFD

Reducing a long position

364

2.5882 USD

5p ordinary

CFD

Reducing a long position

87

2.5882 USD

5p ordinary

CFD

Reducing a long position

177

2.5882 USD

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

14 October 2015

Contact name:

Aadithya Rao and Yiannis Bardis

Telephone number:

+44(20) 7051 9046 / +44(20) 7774 7107

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERGGGGCUUPAGQC
Date   Source Headline
6th Oct 201510:52 amRNSForm 8.3 - Xchanging PLC
6th Oct 201510:03 amRNSForm 8.3 - Xchanging Plc
6th Oct 20159:54 amRNSForm 8.5 (EPT/RI)
6th Oct 20159:43 amRNSForm 8.5 (EPT/RI)
6th Oct 20159:42 amBUSForm 8.3 - Xchanging Plc
5th Oct 20155:05 pmRNSForm 8.3 - Xchanging plc
5th Oct 20153:19 pmRNSForm 8.3 - Xchanging Plc
5th Oct 20152:40 pmRNSForm 8.3 - Xchanging plc
5th Oct 20151:54 pmRNSForm 8.3 - Xchanging Plc
5th Oct 201511:04 amRNSForm 8.3 - Xchanging plc
5th Oct 201510:21 amRNSForm 8.3 - Xchanging Plc
5th Oct 201510:14 amRNSBlocklisting Interim Review
5th Oct 20159:47 amBUSForm 8.3 - Xchanging Plc - Ordinary Shares
5th Oct 20157:00 amRNSStatement re Xchanging plc
5th Oct 20157:00 amRNSStatement re. Press Comment
22nd Sep 20157:00 amRNSDirector appointments
16th Sep 20159:07 amRNSDirectorate Change - Replacement
16th Sep 20157:00 amRNSDirectorate Change
26th Aug 20155:05 pmRNSHolding(s) in Company
19th Aug 20155:03 pmRNSHolding(s) in Company
18th Aug 201512:37 pmRNSHolding(s) in Company
7th Aug 20151:15 pmRNSHolding(s) in Company
5th Aug 20154:14 pmRNSTotal Voting Rights
3rd Aug 201510:13 amRNSBlocklisting Interim Review
31st Jul 201511:12 amRNSHolding(s) in Company
30th Jul 20154:07 pmRNSDirector/PDMR Shareholding
30th Jul 20154:05 pmRNSDirector/PDMR Shareholding
30th Jul 20157:01 amRNSCEO Succession
30th Jul 20157:01 amRNSHalf Yearly Report
8th Jul 20151:52 pmRNSHolding(s) in Company
29th Jun 20152:01 pmRNSTotal Voting Rights
17th Jun 20157:00 amRNSInvestor Seminar
15th Jun 20151:32 pmRNSDirector/PDMR Shareholding
10th Jun 20154:14 pmRNSHolding(s) in Company
1st Jun 20153:14 pmRNSDirector/PDMR Shareholding
14th May 201511:23 amRNSResult of AGM
13th May 201510:18 amRNSDirector Declaration
11th May 201511:37 amRNSDirector/PDMR Shareholding
1st May 20159:40 amRNSBlocklisting Interim Review
1st May 20159:38 amRNSHolding(s) in Company
29th Apr 20158:56 amRNSHolding(s) in Company
29th Apr 20157:04 amRNSCMA clearance of Agencyport acquisition
21st Apr 20155:11 pmRNSHolding(s) in Company
16th Apr 20151:18 pmRNSHolding(s) in Company
16th Apr 201512:46 pmRNSHolding(s) in Company
16th Apr 20157:00 amRNSFirst Quarter 2015 Update
15th Apr 20153:15 pmRNSHolding(s) in Company
10th Apr 20153:58 pmRNSDirector/PDMR Shareholding
10th Apr 20157:00 amRNSNotice of AGM
9th Apr 20157:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.